FDA allows clinuvel’s innovative vitiligo trial. For this trial, the company has made the announcement on Thursday March 3rd, 2011. This announcement for the trial widely known with the terminology, ‘FDA allows clinuvel’s innovative vitiligo trial’ was made at Baar, Switzerland and in Melbourne, Australia. The duration of this trial would be twelve months (one year) – revolving around six months of treatment of the patient and then the remaining six months of follow up.
Complete details about FDA allows clinuvel’s innovative vitiligo trial
Complete details about FDA allows clinuvel’s innovative vitiligo trial
No comments:
Post a Comment